Bilateral versus unilateral cryptorchidism in nonobstructive azoospermia: Testicular sperm extraction outcomes.

Anne-laure Barbotin; Anaïs Dauvergne; Agathe Dumont; Nassima Ramdane; Valérie Mitchell; Jean-marc Rigot; Florence Boitrelle; Geoffroy Robin

Return

Bilateral versus unilateral cryptorchidism in nonobstructive azoospermia: Testicular sperm extraction outcomes.

Author: Anne-Laure BARBOTIN ¹ ; Anaïs DAUVERGNE ² ; Agathe DUMONT ³ ; Nassima RAMDANE ⁴ ; Valérie MITCHELL ¹ ; Jean-Marc RIGOT ⁵ ; Florence BOITRELLE ⁶ ; Geoffroy ROBIN ⁵
Author Information

1. CHU Lille, Reproductive Biology-Spermiology- CECOS Institute, Jeanne de Flandre Hospital, F-59000 Lille, France.
2. CHU Lille, Department of Andrology, Calmette Hospital, F-59000 Lille, France.
3. CHU Lille, Department of Endocrine Gynaecology and Reproductive Medicine, Jeanne de Flandre Hospital, F-59000 Lille, France.
4. CHU Lille, Department of Biostatistics, EA2694, Lille University, F-59000 Lille, France.
5. EA4308: Gametogenesis and Gamete Quality, Lille University, F-59000 Lille, France.
6. Fertility Unit, Poissy-Saint-Germain-en-Laye General Hospital, 78303 Poissy, France.
Publication Type:Journal Article
Keywords: cryptorchidism; intracytoplasmic sperm injection; nonobstructive azoospermia; testicular sperm extraction
MeSH: Adult; Azoospermia/etiology*; Cryptorchidism/complications*; Humans; Male; Retrospective Studies; Sperm Retrieval; Treatment Outcome
From: Asian Journal of Andrology 2019;21(5):445-451
CountryChina
Language:English
Abstract: Cryptorchidism is one of the most frequent causes of nonobstructive azoospermia (NOA) in adulthood. Although it is well known that spermatogenesis is more impaired in bilateral than in unilateral cryptorchidism, previous studies have only described small cohorts or inhomogeneous population. Consequently, we analyzed a cohort of 225 men with only a history of cryptorchidism as sole etiopathogenetic factor for NOA, and compared testicular sperm extraction (TESE) outcomes between men with bilateral versus unilateral cryptorchidism. Our results show no difference in follicle-stimulating hormone (FSH) levels and testicular volumes between men with a history of bilateral cryptorchidism compared to unilateral cryptorchidism (median: 21.3 IU l^-1 vs 19.3 IU l^-1, P = 0.306; and 7.2 ml vs 7.9 ml, P = 0.543, respectively). In addition, sperm retrieval rates were similar (66.2% vs 60.0%, P = 0.353). Using multivariate analysis, we have found that only a low inhibin B level (above the assay's detection limit) was positively associated with successful sperm retrieval (P < 0.05). Regarding intracytoplasmic sperm injection outcomes, we found that cumulative pregnancy rate and live birth rate per cycle were not statistically different between the two groups (17.4% vs 27.8%, P = 0.070; and 16.1% vs 26.4%, P = 0.067, respectively). Unexpectedly, there was no significant difference in hormonal profiles (FSH, luteinizing hormone [LH], testosterone, and inhibin B levels) and TESE outcomes between unilateral versus bilateral cryptorchidism. This suggests that a history of unilateral cryptorchidism could reflect a bilateral testicular impairment. Interestingly, inhibin B level might be a predictor of successful TESE.